Former JP Morgan Private Equity Portfolio Manager Marks Latest Addition to Accelmed’s Growing Team of Healthcare Technology Investment Professionals
Accelmed Partners (âAccelmedâ), a private equity firm focused on acquiring and investing in US lower-middle market health technology companies, today announced that Katherine Relle has joined the company as vice president. Ms. Relle joins Accelmed after working for the Private Equity Group of JP Morgan, where she was Portfolio Manager and Vice President.
âKatherine is a seasoned and growing investment professional who brings considerable private equity investment experience to the company and strengthens our ability to research, identify and execute investments in leading technology companies. health across the United States, âsaid Dr. Uri Geiger, Founder and Managing Partner of Accelmed.
Ms. Relle began her career at JP Morgan Private Banking, holding various positions within the Asset Management and Corporate Strategy teams at JPM. As a portfolio manager within the JP Morgan Private Equity group, Ms. Relle served on the investment committee and helped oversee approximately $ 28 billion in investments. She also co-chaired the Diversity and Inclusion Program Women On the Move and NextGen, JP Morgan’s 50,000-person employee mentorship program, where she worked directly with the bank’s operating committee, including CEO Jamie Dimon. Ms. Relle holds a BA, magna cum laude, from Georgetown University, an M.Sc. from the London School of Economics and an MBA from Columbia Business School.
Ms. Relle is a rising industry leader, having been included in Forbes 30 Under 30 and Investment News 40 Under 40, among others. In 2020, Ms. Relle was appointed Employee of the year by JP Morgan Chase & Co.
âI was extremely impressed with what Uri and her team were able to accomplish in building Accelmed’s exceptional investment portfolio,â commented Ms. Relle. âWith many flourishing innovations in HealthTech, I am extremely excited to join the growing Accelmed team and look forward to building the company’s success and creating significant value in high potential companies. growth. ”
Ms. Relle’s addition comes as Accelmed continues to expand its team of investment professionals and network of industry partners. In June, the company announced the addition of Eric Tansky, senior director of HealthTech, as a general partner, and the addition of Stephen Rubin as a partner. Accelmed also announced the addition of accomplished executives Lewis Pell and Stanley Stern to its executive network.
âThe continued evolution in the larger healthcare technology space in the United States has created a significant demand for experienced investment partners who can guide founders and leadership teams in executing growth initiatives. important, âadded Dr Geiger. âWe are excited to add Katherine to our growing team and look forward to continuing to announce new additions at all levels. ”
About Accelmed partners
Accelmed is a United States-based private equity firm focused on acquiring and investing in lower middle market health technology companies in the United States. Since 2009, Accelmed has deployed more than $ 400 million in companies spanning medical devices, diagnostics, digital health, and technology-based healthcare services. Accelmed seeks to accelerate value and evolve innovation in healthcare technology by leveraging the team’s experience, operational and financial expertise and strong global relationships. For more information, please visit https://www.accelmed.com/.